How I treat statin-associated side effects in an outpatient setting.
Vishnu Priya PulipatiMichael H DavidsonPublished in: Future cardiology (2021)
Dyslipidemia promotes atherosclerosis and causes cardiovascular diseases. Statins are potent lipid-lowering medications with a cardiovascular mortality benefit. They are generally safe and well tolerated but sometimes can be associated with side effects of variable severity. The most common side effect is statin-associated muscle symptoms. Uncommon side effects include new-onset diabetes mellitus and elevation in liver enzymes. These effects can lead to noncompliance and premature discontinuation of the medication. Hence, it is crucial to identify patients with true statin-associated side effects (SASE) to ensure optimal statin use. The appropriate evaluation of the patient before starting statins and proactive utilization of available diagnostic tests to rule out alternate etiologies mimicking adverse effects are essential for accurate diagnosis of SASE. In patients with true SASE, timely intervention with modified statin or non-statins is beneficial. Herein, we discuss key clinical trial data on statins and non-statins, and describe our center's approach toward patients with SASE.
Keyphrases
- cardiovascular disease
- cardiovascular events
- clinical trial
- cardiovascular risk factors
- type diabetes
- coronary artery disease
- randomized controlled trial
- skeletal muscle
- emergency department
- artificial intelligence
- risk factors
- low density lipoprotein
- metabolic syndrome
- adverse drug
- depressive symptoms
- double blind